# Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan

> **NCT01716260** · — · COMPLETED · sponsor: **Menzies School of Health Research** · enrollment: 24 (actual)

## Conditions studied

- Vivax Malaria

## Interventions

- **DRUG:** Chloroquine
- **DRUG:** Primaquine

## Key facts

- **NCT ID:** NCT01716260
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716260, "Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01716260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*